|
Volumn 19, Issue 5, 2009, Pages 1329-1331
|
(2-Aryl-5-methylimidazol-4-ylcarbonyl)guanidines and (2-aryl-5-methyloxazol-4-ylcarbonyl)guanidines as NHE-1 inhibitors
|
Author keywords
(2 Aryl 5 methylimidazol 5 ylcarbonyl)guanidine; Cardioprotective; Sodium hydrogen exchanger
|
Indexed keywords
BENZENE DERIVATIVE;
FURAN DERIVATIVE;
GUANIDINE DERIVATIVE;
IMIDAZOLE DERIVATIVE;
OXAZOLE DERIVATIVE;
PROTEIN INHIBITOR;
SODIUM PROTON EXCHANGE PROTEIN 1;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HEART INFARCTION;
HEART PROTECTION;
IN VITRO STUDY;
IN VIVO STUDY;
INHIBITION KINETICS;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
CARDIOTONIC AGENTS;
CATION TRANSPORT PROTEINS;
GUANIDINES;
HUMANS;
IMIDAZOLES;
MYOCARDIAL INFARCTION;
RATS;
SODIUM-HYDROGEN ANTIPORTER;
|
EID: 60449119102
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2009.01.060 Document Type: Article |
Times cited : (21)
|
References (23)
|